Ceftiofur hydrochloride

Name: Ceftiofur hydrochloride
Brand: SIAL
Price: 99.1 EUR

VETRANAL^®, analytical standard

Sinonimo/i:

(6R,7R)-7-{[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino}-3-{[(2-furanylcarbonyl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride, 3-[(2-Furylcarbonyl)thio]methyl]-7-[2-(2-amino-4-thiazolyl)-2-(methoxyiminoacetamido)-3-cephem-4-carboxylic acid hydrochloride

Slide 1 of 1

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

100 MG

99,10 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.

Richiedi un ordine in blocco

Informazioni su questo articolo

Formula empirica (notazione di Hill):

C₁₉H₁₇N₅O₇S₃ · HCl

Numero CAS:

103980-44-5

Peso molecolare:

560.02

NACRES:

NA.24

PubChem Substance ID:

329754200

UNSPSC Code:

41116107

MDL number:

MFCD04038020

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

Servizio Tecnico

Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.

Permettici di aiutarti

Nome del prodotto

Ceftiofur hydrochloride, VETRANAL^®, analytical standard

InChI

1S/C19H17N5O7S3.ClH/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10;/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28);1H/b23-11-;/t12-,16-;/m1./s1

SMILES string

Cl.CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c4csc(N)n4

InChI key

KEQFDTJEEQKVLM-JUODUXDSSA-N

grade

analytical standard

product line

VETRANAL^®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)

format

neat

Quality Level

100

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Controlled Substances & Illicit Drug Standards

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 4

Questo articolo	PHR2665	PHR2667	34001
Supelco 32422 Ceftiofur hydrochloride	Supelco PHR2665 Cefdinir	Supelco PHR2667 Cefdinir Related Compound B	Supelco 34001 Ceftiofur
grade analytical standard	grade certified reference material, pharmaceutical secondary standard	grade certified reference material, pharmaceutical secondary standard	grade analytical standard
format neat	format -	format -	format neat
product line VETRANAL^®	product line -	product line -	product line VETRANAL^®
shelf life limited shelf life, expiry date on the label	shelf life -	shelf life -	shelf life limited shelf life, expiry date on the label
technique(s) HPLC: suitable	technique(s) -	technique(s) -	technique(s) HPLC: suitable, gas chromatography (GC): suitable
application(s) forensics and toxicology pharmaceutical (small molecule)	application(s) pharmaceutical	application(s) pharmaceutical	application(s) forensics and toxicology pharmaceutical (small molecule)

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Other Notes

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Minimum inhibitory concentrations of Staphylococcus aureus recovered from clinical and subclinical cases of bovine mastitis.

L Oliveira et al.

Journal of dairy science, 95(4), 1913-1920 (2012-03-31)

Antimicrobials are often used for treatment of bovine mastitis and the possibility of selection for resistant bacteria must be considered. The objectives of this study were to determine the minimum inhibitory concentration of Staphylococcus aureus recovered from cases of clinical

Pharmacokinetics of a single intramuscular injection of ceftiofur crystalline-free acid in American black ducks (Anas rubripes).

Katharine L Hope et al.

American journal of veterinary research, 73(5), 620-627 (2012-04-27)

To determine the pharmacokinetic properties of 1 IM injection of ceftiofur crystalline-free acid (CCFA) in American black ducks (Anas rubripes). 20 adult American black ducks (6 in a preliminary experiment and 14 in a primary experiment). Dose and route of

Association between metabolic diseases and the culling risk of high-yielding dairy cows in a transition management facility using survival and decision tree analysis.

M Probo et al.

Journal of dairy science, 101(10), 9419-9429 (2018-08-21)

The objective of this study was to assess the association between individual metabolic diseases (MD) and multiple MD (MD+) in the transition period (±3 wk relative to calving) and the culling risk in the first 120 d in milk (DIM)

Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos).

J E Dechant et al.

Journal of veterinary pharmacology and therapeutics, 36(2), 122-129 (2012-04-11)

Six adult male alpacas received one subcutaneous administration of ceftiofur crystalline free acid (CCFA) at a dosage of 6.6 mg/kg. After a washout period, the same alpacas received three subcutaneous doses of 6.6 mg/kg CCFA at 5-day intervals. Blood samples

Disposition of desfuroylceftiofur acetamide in serum, placental tissue, fetal fluids, and fetal tissues after administration of ceftiofur crystalline free acid (CCFA) to pony mares with placentitis.

M L Macpherson et al.

Journal of veterinary pharmacology and therapeutics, 36(1), 59-67 (2012-03-28)

The objective of this study was to determine the pharmacokinetics of CCFA in mares with placentitis and evaluate the disposition of the drug in fetal fluids, fetal membranes, colostrum, and serum of foals. A secondary objective was to obtain pilot

Visualizza tutti i documenti correlati

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica

Ceftiofur hydrochloride